 |
This Is MS Multiple Sclerosis Community: Knowledge & SupportWelcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones. |
| It is currently Mon Jun 17, 2013 10:45 pm |
|
All times are UTC - 8 hours [ DST ] |
 
|
Page 1 of 1 |
[ 1 post ] |
|
| Author | Message | |||||
|---|---|---|---|---|---|---|
| Rici |
|
|||||
Joined: Thu Nov 12, 2009 4:00 pm Posts: 286 Location: Poland Bialystok |
|
|||||
| Top |  |
|||||
 |
||||||
|
|
Page 1 of 1 |
[ 1 post ] |
|
All times are UTC - 8 hours [ DST ] |
| Topics | Author | Replies | Views | Last post | |
|---|---|---|---|---|---|
 | Tysabri: among them, 665 people have Death. | 11 | 581 | Sun Jun 16, 2013 4:34 pm | |
 | Novartis says FTY720 trial continues despite death | 1 | 2033 | Sat Jul 05, 2008 6:15 am | |
| "Side effects : death" | 8 | 1159 | Mon Jun 10, 2013 11:06 am | |
| Phase-III Laquinimod trial completed patient enrollment | 0 | 1161 | Tue Nov 18, 2008 7:46 am | |
| Tysabri | 3 | 1516 | Thu Oct 27, 2005 7:18 am | |
Who is online |
Users browsing this forum: No registered users |
| You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum |
News 
Site map 
SitemapIndex 
RSS Feed Channel list
Login
Register
FAQ
